\-\ Texto\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\ neurologic\\ exam\\ prior\\ to\\ treatment\ \(0\)\
\-\ left\\ sided\\ densely\\ hemiparetic\\.\ \(0\)\
\-\ left\\ upper\\ extremity\\ muscle\\ strength\\ 1\\/5\\.\ \(0\)\
\-\ left\\ lower\\ extremity\\ muscle\\ strength\\ 0\\/5\\.\ \(0\)\
\-\ right\\ upper\\/lower\\ extremity\\ muscle\\ strength\\ 5\\/5\\.\ \(0\)\
\-\ bilateral\\ lower\\ extremity\\ deep\\ tendon\\ reflexes\\ brisk\\ 2\\+\\.\ \(0\)\
\-\ labs\\:\ \(4\)\
\-\ troponini\\ \\<0\\.04\ \(0\)\
\-\ ck\\ total\\ 115\ \(0\)\
\-\ total\\ cholesterol\\ 150\ \(0\)\
\-\ triglyceride\\ 535\ \(0\)\
\-\ pt\\ 10\\.8\ \(0\)\
\-\ inr\\ 1\\.0\ \(0\)\
\-\ hypercoagulopathy\\ lab\\ work\\ up\\ was\\ negative\\.\ \(0\)\
\-\ additional\\ tests\\:\ \(0\)\
\-\ bilateral\\ carotid\\ duplex\\ doppler\\ was\\ negative\ \(0\)\
\-\ supportive\\ measures\\ and\\ rehabilitation\\.\ \(0\)\
\-\ thrombolytic\\ therapy\\.\ \(2\)\
\-\ neuro\\ exam\\ after\\ tpa\\ administration\\:\ \(0\)\
\-\ pupils\\ reactive\\ bilaterally\\.\ \(0\)\
\-\ no\\ change\\ in\\ muscle\\ strength\\ or\\ reflexes\\.\ \(0\)\
\-\ hyperdensity\\ within\\ the\\ right\\ middle\\ cerebral\\ artery\\.\ \(0\)\
\-\ increased\\ right\\ sided\\ cerebral\\ edema\\.\\ \\ midline\\ shift\\ appreciated\\.\ \(0\)\
\-\ cerebral\\ infarction\\,\\ hyperdense\\ middle\\ cerebral\\ artery\\ sign\ \(0\)\
\-\ thromboembolic\\ infart\\-\\-arterial\ \(0\)\
\-\ infarct\\-venous\ \(0\)\
\-\ tumor\ \(1901\)\
\-\ traumatic\\ edema\ \(3\)\
\-\ 37\\ y\\/o\\ hispanic\\ man\\ with\\ no\\ prior\\ medical\\ history\\,\\ presents\\ with\\ sudden\\ and\\ complete\\ left\\ hemiplegia\\ and\\ left\\ facial\\ droop\\ as\\ reported\\ by\\ family\\ member\\.\\ \\ \\ further\\ details\\ elucidated\\ include\\ that\\ the\\ patient\\ had\\ complained\\ of\\ a\\ headache\\ and\\ 45\\ minutes\\ later\\ developed\\ the\\ hemiplegia\\ while\\ operating\\ a\\ vehicle\\.\\ \\ althought\\ there\\ was\\ no\\ motor\\ vehicle\\ accident\\ an\\ ambulance\\ was\\ called\\ to\\ the\\ scene\\.\ \(0\)\
\-\ upon\\ arrival\\ to\\ the\\ er\\,\\ the\\ patient\\ was\\ initially\\ conversive\\ but\\ suddenly\\ became\\ altered\\ with\\ vomiting\\ and\\ agitation\\.\\ \\ the\\ patient\\ was\\ intubated\\ for\\ airway\\ protection\\.\\ \\ his\\ right\\ side\\ of\\ the\\ body\\ remained\\ very\\ active\\.\\ \\ a\\ computed\\ tomography\\ of\\ the\\ head\\ was\\ performed\\ immediately\\ and\\ it\\ demonstrated\\ no\\ acute\\ bleed\\.\\ \\ with\\ no\\ other\\ bleeding\\ risks\\ determined\\,\\ the\\ patient\\ was\\ administered\\ tpa\\ within\\ two\\ hours\\ of\\ the\\ incident\\.\\ \\ subsequent\\ head\\ ct\\'s\\ performed\\ during\\ the\\ patient\\'s\\ hospital\\ course\\ demonstrated\\ the\\ following\\ findings\\ discussed\\ here\\.\ \(0\)\
\-\ more\\ significance\\ was\\ given\\ to\\ the\\ hyperdense\\ middle\\ cerebral\\ artery\\ sign\\ early\\ in\\ the\\ patient\\'s\\ clinical\\ course\\.y\\.\\ \\ as\\ the\\ contrast\\ resolution\\ of\\ ct\\ improved\\,\\ a\\ differential\\ in\\ density\\ between\\ the\\ brain\\ and\\ the\\ intracranial\\ blood\\ vessels\\ became\\ apparent\\.\\ \\ \ \(0\)\
\-\ currently\\,\\ to\\ consider\\ the\\ hyperdense\\ middle\\ cerebral\\ artery\\ sign\\ to\\ be\\ positive\\,\\ it\\ must\\ be\\ hyperdense\\ in\\ relation\\ to\\ the\\ contralateral\\ middle\\ cerebral\\ artery\\.\\ \\ comparison\\ to\\ the\\ density\\ of\\ the\\ parenchyma\\ of\\ the\\ brain\\ is\\ not\\ enough\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cerebral\\:\\ 0\\.0554094265036056\ \(0\)\
\-\ hyperdense\\:\\ 0\\.04569223146199459\ \(0\)\
\-\ middle\\:\\ 0\\.041780200128909595\ \(0\)\
\-\ strength\\:\\ 0\\.04055227703871895\ \(0\)\
\-\ tpa\\:\\ 0\\.03756020831410932\ \(0\)\
\-\ artery\\:\\ 0\\.03401778064315774\ \(0\)\
\-\ extremity\\:\\ 0\\.033424160103127674\ \(0\)\
\-\ muscle\\:\\ 0\\.03282690089226037\ \(0\)\
\-\ hemiplegia\\:\\ 0\\.030146869484591186\ \(0\)\
\-\ became\\:\\ 0\\.024656822484361136\ \(0\)\
\-\ was\\:\\ 0\\.02378207941155931\ \(0\)\
\-\ sign\\:\\ 0\\.02374689707297383\ \(0\)\
\-\ hemiparetic\\:\\ 0\\.02357090487691577\ \(0\)\
\-\ troponini\\:\\ 0\\.02357090487691577\ \(0\)\
\-\ 535\\:\\ 0\\.02357090487691577\ \(0\)\
\-\ hypercoagulopathy\\:\\ 0\\.02357090487691577\ \(0\)\
\-\ infart\\:\\ 0\\.02357090487691577\ \(0\)\
\-\ infarct\\-venous\\:\\ 0\\.02357090487691577\ \(0\)\
\-\ conversive\\:\\ 0\\.02357090487691577\ \(0\)\
\-\ course\\.y\\:\\ 0\\.02357090487691577\ \(0\)\
\-\ 0\\/5\\:\\ 0\\.021717570169536238\ \(0\)\
\-\ althought\\:\\ 0\\.021717570169536238\ \(0\)\
\-\ reflexes\\:\\ 0\\.02163012727005793\ \(0\)\
\-\ vehicle\\:\\ 0\\.021279339663181927\ \(0\)\
\-\ 1\\/5\\:\\ 0\\.02063343886443419\ \(0\)\
\-\ upper\\/lower\\:\\ 0\\.02063343886443419\ \(0\)\
\-\ triglyceride\\:\\ 0\\.02063343886443419\ \(0\)\
\-\ elucidated\\:\\ 0\\.019864235462156703\ \(0\)\
\-\ total\\:\\ 0\\.01967764698885688\ \(0\)\
\-\ 0\\.04\\:\\ 0\\.01878010415705466\ \(0\)\
\-\ member\\:\\ 0\\.01878010415705466\ \(0\)\
\-\ protection\\:\\ 0\\.01878010415705466\ \(0\)\
\-\ scene\\:\\ 0\\.01801090075477717\ \(0\)\
\-\ agitation\\:\\ 0\\.01801090075477717\ \(0\)\
\-\ 115\\:\\ 0\\.017695972851952613\ \(0\)\
\-\ 10\\.8\\:\\ 0\\.017695972851952613\ \(0\)\
\-\ thrombolytic\\:\\ 0\\.01715942019028911\ \(0\)\
\-\ hyperdensity\\:\\ 0\\.01715942019028911\ \(0\)\
\-\ ck\\:\\ 0\\.016926769449675125\ \(0\)\
\-\ sided\\:\\ 0\\.01689586424142591\ \(0\)\
\-\ densely\\:\\ 0\\.016514601856554116\ \(0\)\
\-\ thromboembolic\\:\\ 0\\.016514601856554116\ \(0\)\
\-\ details\\:\\ 0\\.016514601856554116\ \(0\)\
\-\ suddenly\\:\\ 0\\.016514601856554116\ \(0\)\
\-\ 150\\:\\ 0\\.016157566047397636\ \(0\)\
\-\ brisk\\:\\ 0\\.015698073381818337\ \(0\)\
\-\ droop\\:\\ 0\\.015698073381818337\ \(0\)\
\-\ incident\\:\\ 0\\.015560925535862318\ \(0\)\
\-\ duplex\\:\\ 0\\.015187230502773659\ \(0\)\
\-\ ambulance\\:\\ 0\\.015187230502773659\ \(0\)\
\-\ \\'s\\:\\ 0\\.015112673409361324\ \(0\)\
\-\ rehabilitation\\:\\ 0\\.015073434742295593\ \(0\)\
\-\ density\\:\\ 0\\.015035461801390156\ \(0\)\
\-\ arrival\\:\\ 0\\.014758506839471039\ \(0\)\
\-\ risks\\:\\ 0\\.014758506839471039\ \(0\)\
\-\ significance\\:\\ 0\\.014567440090855678\ \(0\)\
\-\ cholesterol\\:\\ 0\\.014476794230760273\ \(0\)\
\-\ hispanic\\:\\ 0\\.014476794230760273\ \(0\)\
\-\ operating\\:\\ 0\\.01438912090770415\ \(0\)\
\-\ relation\\:\\ 0\\.01438912090770415\ \(0\)\
\-\ inr\\:\\ 0\\.014304231340018105\ \(0\)\
\-\ 1\\.0\\:\\ 0\\.014221954177807533\ \(0\)\
\-\ brain\\:\\ 0\\.013750542905362362\ \(0\)\
\-\ patient\\:\\ 0\\.013742116538765585\ \(0\)\
\-\ negative\\:\\ 0\\.0136477013977266\ \(0\)\
\-\ enough\\:\\ 0\\.013641567800166284\ \(0\)\
\-\ intubated\\:\\ 0\\.013577135844072538\ \(0\)\
\-\ demonstrated\\:\\ 0\\.013408663007791269\ \(0\)\
\-\ administered\\:\\ 0\\.013164968250951528\ \(0\)\
\-\ bleed\\:\\ 0\\.013058002115620781\ \(0\)\
\-\ head\\:\\ 0\\.012960434815903187\ \(0\)\
\-\ altered\\:\\ 0\\.012955151097364644\ \(0\)\
\-\ edema\\:\\ 0\\.01292472454241332\ \(0\)\
\-\ left\\:\\ 0\\.01278215600632239\ \(0\)\
\-\ performed\\:\\ 0\\.012741060594798497\ \(0\)\
\-\ 5\\/5\\:\\ 0\\.012714105383476147\ \(0\)\
\-\ airway\\:\\ 0\\.012714105383476147\ \(0\)\
\-\ contralateral\\:\\ 0\\.012623459523380742\ \(0\)\
\-\ pupils\\:\\ 0\\.012493004538970495\ \(0\)\
\-\ discussed\\:\\ 0\\.012493004538970495\ \(0\)\
\-\ remained\\:\\ 0\\.012450896632638571\ \(0\)\
\-\ consider\\:\\ 0\\.01240944158842476\ \(0\)\
\-\ tomography\\:\\ 0\\.01221129193025973\ \(0\)\
\-\ complained\\:\\ 0\\.012062709440540983\ \(0\)\
\-\ computed\\:\\ 0\\.012062709440540983\ \(0\)\
\-\ called\\:\\ 0\\.01199140396705927\ \(0\)\
\-\ tests\\:\\ 0\\.011956451877306989\ \(0\)\
\-\ determined\\:\\ 0\\.011921950794858038\ \(0\)\
\-\ here\\:\\ 0\\.011921950794858038\ \(0\)\
\-\ comparison\\:\\ 0\\.011887889228608227\ \(0\)\
\-\ minutes\\:\\ 0\\.011821040826989463\ \(0\)\
\-\ neuro\\:\\ 0\\.011788233092786751\ \(0\)\
\-\ prior\\:\\ 0\\.011733223380761302\ \(0\)\
\-\ 2\\+\\:\\ 0\\.011692158201807972\ \(0\)\
\-\ no\\:\\ 0\\.011503264046842272\ \(0\)\
\-\ 37\\:\\ 0\\.011480561088014592\ \(0\)\
\-\ immediately\\:\\ 0\\.011339057340810468\ \(0\)\
\-\ lab\\:\\ 0\\.011178581378975568\ \(0\)\
\-\ appreciated\\:\\ 0\\.011127160625157687\ \(0\)\
\-\ bilateral\\:\\ 0\\.011089934381360663\ \(0\)\
\-\ doppler\\:\\ 0\\.011051837424711974\ \(0\)\
\-\ improved\\:\\ 0\\.010883920576479272\ \(0\)\
\-\ shift\\:\\ 0\\.010837819489755995\ \(0\)\
\-\ reactive\\:\\ 0\\.010815063635028965\ \(0\)\
\-\ work\\:\\ 0\\.010704101787684706\ \(0\)\
\-\ tendon\\:\\ 0\\.010660975098032613\ \(0\)\
\-\ sudden\\:\\ 0\\.010556106881045229\ \(0\)\
\-\ 45\\:\\ 0\\.010556106881045229\ \(0\)\
\-\ \\-\\-\\:\\ 0\\.010495105068836216\ \(0\)\
\-\ must\\:\\ 0\\.010415875663471585\ \(0\)\
\-\ accident\\:\\ 0\\.01037712430704761\ \(0\)\
\-\ lower\\:\\ 0\\.010277337269325467\ \(0\)\
\-\ it\\:\\ 0\\.010271916494828965\ \(0\)\
\-\ carotid\\:\\ 0\\.010245753481973695\ \(0\)\
\-\ supportive\\:\\ 0\\.010103117169927458\ \(0\)\
\-\ apparent\\:\\ 0\\.010103117169927458\ \(0\)\
\-\ exam\\:\\ 0\\.010038684170853145\ \(0\)\
\-\ arterial\\:\\ 0\\.01000092141372372\ \(0\)\
\-\ facial\\:\\ 0\\.009934898385407218\ \(0\)\
\-\ bleeding\\:\\ 0\\.009918644251513148\ \(0\)\
\-\ resolution\\:\\ 0\\.009854598152522525\ \(0\)\
\-\ measures\\:\\ 0\\.00977663937099457\ \(0\)\
\-\ parenchyma\\:\\ 0\\.009730932329926922\ \(0\)\
\-\ intracranial\\:\\ 0\\.009656448494357494\ \(0\)\
\-\ right\\:\\ 0\\.009643119883533868\ \(0\)\
\-\ traumatic\\:\\ 0\\.009569723158119115\ \(0\)\
\-\ neurologic\\:\\ 0\\.009541428748144417\ \(0\)\
\-\ motor\\:\\ 0\\.009541428748144417\ \(0\)\
\-\ administration\\:\\ 0\\.009485722633430935\ \(0\)\
\-\ family\\:\\ 0\\.009364471777873558\ \(0\)\
\-\ infarction\\:\\ 0\\.009338257873871898\ \(0\)\
\-\ upon\\:\\ 0\\.009338257873871898\ \(0\)\
\-\ initially\\:\\ 0\\.009299412685201016\ \(0\)\
\-\ deep\\:\\ 0\\.009248481682605576\ \(0\)\
\-\ vessels\\:\\ 0\\.00919850271733244\ \(0\)\
\-\ additional\\:\\ 0\\.00916162217687165\ \(0\)\
\-\ to\\:\\ 0\\.009135146704662808\ \(0\)\
\-\ \\:\\:\\ 0\\.009066375529336887\ \(0\)\
\-\ currently\\:\\ 0\\.009053937954577693\ \(0\)\
\-\ hours\\:\\ 0\\.008984484782376461\ \(0\)\
\-\ change\\:\\ 0\\.008905672434427388\ \(0\)\
\-\ subsequent\\:\\ 0\\.008894600796282919\ \(0\)\
\-\ midline\\:\\ 0\\.008839920019621713\ \(0\)\
\-\ \\<\\:\\ 0\\.008818357025405857\ \(0\)\
\-\ developed\\:\\ 0\\.008796966536991215\ \(0\)\
\-\ er\\:\\ 0\\.008765198280609524\ \(0\)\
\-\ vomiting\\:\\ 0\\.008723419355734974\ \(0\)\
\-\ active\\:\\ 0\\.008723419355734974\ \(0\)\
\-\ within\\:\\ 0\\.0087172802587491\ \(0\)\
\-\ course\\:\\ 0\\.0086217418274215\ \(0\)\
\-\ hospital\\:\\ 0\\.00860186220579712\ \(0\)\
\-\ the\\:\\ 0\\.008501961358779127\ \(0\)\
\-\ pt\\:\\ 0\\.00849509025302875\ \(0\)\
\-\ early\\:\\ 0\\.008356040025781919\ \(0\)\
\-\ reported\\:\\ 0\\.008329077140577037\ \(0\)\
\-\ very\\:\\ 0\\.00829354443437735\ \(0\)\
\-\ later\\:\\ 0\\.008249782462547924\ \(0\)\
\-\ complete\\:\\ 0\\.008041112122957364\ \(0\)\
\-\ labs\\:\\ 0\\.007946454563997694\ \(0\)\
\-\ side\\:\\ 0\\.007915632357657944\ \(0\)\
\-\ headache\\:\\ 0\\.007847554645897856\ \(0\)\
\-\ given\\:\\ 0\\.007832658803519632\ \(0\)\
\-\ bilaterally\\:\\ 0\\.007504559461293859\ \(0\)\
\-\ body\\:\\ 0\\.007420491210398621\ \(0\)\
\-\ positive\\:\\ 0\\.007414132594342557\ \(0\)\
\-\ further\\:\\ 0\\.007265893427273417\ \(0\)\
\-\ differential\\:\\ 0\\.007253903287039918\ \(0\)\
\-\ between\\:\\ 0\\.007241966674396374\ \(0\)\
\-\ while\\:\\ 0\\.007188901710835062\ \(0\)\
\-\ be\\:\\ 0\\.007046827397561118\ \(0\)\
\-\ medical\\:\\ 0\\.007030240107128353\ \(0\)\
\-\ clinical\\:\\ 0\\.007030240107128353\ \(0\)\
\-\ during\\:\\ 0\\.006992003342042267\ \(0\)\
\-\ as\\:\\ 0\\.0069121791759044265\ \(0\)\
\-\ his\\:\\ 0\\.00658526477980463\ \(0\)\
\-\ two\\:\\ 0\\.006543666410737983\ \(0\)\
\-\ following\\:\\ 0\\.006484699884762428\ \(0\)\
\-\ include\\:\\ 0\\.006409501304893815\ \(0\)\
\-\ ct\\:\\ 0\\.006391998146481513\ \(0\)\
\-\ y\\/o\\:\\ 0\\.006327885106469627\ \(0\)\
\-\ blood\\:\\ 0\\.006236393242003474\ \(0\)\
\-\ up\\:\\ 0\\.006143976339717174\ \(0\)\
\-\ therapy\\:\\ 0\\.006108665230589874\ \(0\)\
\-\ more\\:\\ 0\\.005714375158588679\ \(0\)\
\-\ acute\\:\\ 0\\.00564138858049865\ \(0\)\
\-\ increased\\:\\ 0\\.005589531502138117\ \(0\)\
\-\ upper\\:\\ 0\\.005513584238953792\ \(0\)\
\-\ man\\:\\ 0\\.0054035610777807466\ \(0\)\
\-\ tumor\\:\\ 0\\.005326824335857783\ \(0\)\
\-\ other\\:\\ 0\\.005266413231824729\ \(0\)\
\-\ contrast\\:\\ 0\\.005114373494138784\ \(0\)\
\-\ \\,\\:\\ 0\\.005066765932141742\ \(0\)\
\-\ had\\:\\ 0\\.004930079730590129\ \(0\)\
\-\ but\\:\\ 0\\.004873003478699298\ \(0\)\
\-\ findings\\:\\ 0\\.0048632003630747584\ \(0\)\
\-\ after\\:\\ 0\\.004727275942805354\ \(0\)\
\-\ presents\\:\\ 0\\.0046674981163313525\ \(0\)\
\-\ treatment\\:\\ 0\\.004624644277007719\ \(0\)\
\-\ in\\:\\ 0\\.004506922247489357\ \(0\)\
\-\ a\\:\\ 0\\.004241709110359372\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.0041898779454435505\ \(0\)\
\-\ that\\:\\ 0\\.0039464725362535385\ \(0\)\
\-\ by\\:\\ 0\\.003804467655734959\ \(0\)\
\-\ there\\:\\ 0\\.003400308974505317\ \(0\)\
\-\ and\\:\\ 0\\.0033691525137046234\ \(0\)\
\-\ not\\:\\ 0\\.003301654202518544\ \(0\)\
\-\ an\\:\\ 0\\.0031595317226864434\ \(0\)\
\-\ history\\:\\ 0\\.0031556538441365866\ \(0\)\
\-\ or\\:\\ 0\\.002677868312737186\ \(0\)\
\-\ \\.\\:\\ 0\\.00246788218858557\ \(0\)\
\-\ of\\:\\ 0\\.0021805524213527245\ \(0\)\
\-\ for\\:\\ 0\\.0019494870284564574\ \(0\)\
\-\ is\\:\\ 0\\.0015034512791035444\ \(0\)\
\-\ with\\:\\ 0\\.0012513815624587137\ \(0\)\
